Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, Scott H. Donaldson et autres
us, ca (code pays fourni par la source)